MPLT · MapLight Therapeutics, Inc.
← all insidersPharmaceutical Preparations · Listed on Nasdaq
Open-market insider flow over 30d · 90d · 180d · 365d · filter in table · CSV · JSON
Open-market trades46
Distinct insiders7
Bought$148.7K
Sold$11.46M
Net flow$-11.31M
Recent filings
How to read this
- Filed
- Date the Form 4 was filed with the SEC. Insiders must file within 2 business days of the trade.
- Ticker
- The issuer's stock symbol. Select it to open that company's insider-activity page.
- Issuer
- The company whose shares were traded.
- Sector
- The issuer's industry (SEC SIC classification). Select a value to filter to that sector.
- Insider
- The reporting person: an officer, director, or 10% owner. Select a name to see all of their trades.
- Role
- The insider's relationship to the company: director, officer, or 10% owner.
- Code
- SEC transaction code describing the kind of transaction. Full official definitions are under “Transaction codes” below. A dot marks an open-market trade (P/S), the highest-conviction signal.
- Side
- Direction of the trade, from the filing's Acquired (A) ▲ / Disposed of (D) ▼ field: a buy or a sell.
- 10b5-1
- Trade made under a pre-arranged Rule 10b5-1 plan: scheduled in advance, not a discretionary decision (generally lower signal).
- Shares
- Number of shares in this transaction.
- Price
- Reported price per share. Blank for grants, gifts, and other trades with no stated price.
- Value
- Transaction value = shares × price. Left blank for grants, option exercises, gifts, and conversions, which have no cash price (see Own Δ for their impact).
- Owned after
- Form 4 column “Amount of Securities Beneficially Owned Following Reported Transaction(s)”: shares the insider held (directly or indirectly) immediately after this trade.
- Own Δ
- How much this trade changed the insider's own holding versus what they held just before it (not a share of the company). +45% grew it by 45%, 2.0× more than doubled it, −100% sold the entire stake, “new” built a position from nothing.
- Co. Δ
- Change in the insider's stake as a share of the whole company from this trade (transaction shares ÷ shares outstanding). The “(now …)” figure is their resulting total stake. Based on the latest reported shares outstanding; blank when unavailable.
- D/I
- Form 4 column “Ownership Form: Direct (D) or Indirect (I)”. Indirect holdings (for example, through a trust, fund, or family member) are detailed in the filing's “Nature of Indirect Beneficial Ownership.”
- Lag
- Days from the trade date to the filing date (Form 4 is due within 2 business days).
Transaction codes
Verbatim from the SEC's General Instructions for Forms 3, 4 and 5.
- P
- Open market or private purchase of non-derivative or derivative security
- S
- Open market or private sale of non-derivative or derivative security
- A
- Grant, award or other acquisition pursuant to Rule 16b-3(d)
- D
- Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
- F
- Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
- M
- Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
- G
- Bona fide gift
- C
- Conversion of derivative security
- X
- Exercise of in-the-money or at-the-money derivative security
- J
- Other acquisition or disposition (describe transaction)
| Filed ↓Date the Form 4 was filed with the SEC (due within 2 business days of the trade). | Insider | Role | CodeSEC transaction code describing the kind of transaction. See “How to read this” above for the official SEC definition of each code. The dot marks an open-market trade (P/S). | SideDirection of the trade: a buy (acquired ▲) or a sell (disposed ▼). | Shares | PriceReported price per share. Blank for trades with no stated price. | ValueTransaction value = shares × price. Left blank for grants, option exercises, gifts, and conversions, which have no cash price (see Own Δ). | Owned afterShares the insider held (directly or indirectly) immediately after this trade. | Own ΔHow much this trade changed the insider's own holding versus what they held just before it (not a share of the company). +45% grew it by 45%, 2.0× more than doubled it, −100% sold the entire stake, “new” built a position from nothing. | Co. ΔChange in the insider's stake as a share of the whole company from this trade (transaction shares ÷ shares outstanding). The “(now …)” figure is their resulting total stake in the company. Based on the latest reported shares outstanding; blank when unavailable. | Link to SEC filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-08-19 | Lillie James Woodruff | Officer (Chief Scientific Officer) | A | ▲ buy | 31,395→ 31,395 Voting Common Stock | — | — | 31,395 | — | — | filing |
| 2026-08-19 | Lillie James Woodruff | Officer (Chief Scientific Officer) | A | ▲ buy | 7,7300 | — | — | 210,110 | +4% | +0.02% (now 0.50%) | filing |
| 2026-08-19 | Kroeger Christopher A. | Director, Officer (Chief Executive Officer) | A | ▲ buy | 93,955→ 93,955 Voting Common Stock | — | — | 93,955 | — | — | filing |
| 2026-08-19 | Kroeger Christopher A. | Director, Officer (Chief Executive Officer) | A | ▲ buy | 23,1450 | — | — | 1,269,600 | +2% | +0.05% (now 3.0%) | filing |
| 2026-08-19 | Kreitzer Anatol | Officer (Chief Discovery Officer) | A | ▲ buy | 24,455→ 24,455 Voting Common Stock | — | — | 24,455 | — | — | filing |
| 2026-08-19 | Kreitzer Anatol | Officer (Chief Discovery Officer) | A | ▲ buy | 6,0200 | — | — | 180,926 | +3% | +0.01% (now 0.43%) | filing |
| 2026-08-19 | Hanson Kristopher | Officer (General Counsel) | A | ▲ buy | 31,395→ 31,395 Voting Common Stock | — | — | 31,395 | — | — | filing |
| 2026-08-19 | Hanson Kristopher | Officer (General Counsel) | A | ▲ buy | 7,7300 | — | — | 153,553 | +5% | +0.02% (now 0.36%) | filing |
| 2026-08-19 | GILLIS JONATHAN | Officer (CAO and Interim CFO) | A | ▲ buy | 2,813→ 2,813 Voting Common Stock | — | — | 2,813 | — | — | filing |
| 2026-08-19 | GILLIS JONATHAN | Officer (CAO and Interim CFO) | A | ▲ buy | 24,455→ 24,455 Voting Common Stock | — | — | 24,455 | — | — | filing |
| 2026-08-19 | GILLIS JONATHAN | Officer (CAO and Interim CFO) | A | ▲ buy | 2,2220 | — | — | 152,482 | +1% | +<0.01% (now 0.36%) | filing |
| 2026-08-19 | GILLIS JONATHAN | Officer (CAO and Interim CFO) | A | ▲ buy | 6,0200 | — | — | 150,260 | +4% | +0.01% (now 0.35%) | filing |
| 2026-08-19 | Foff Erin Pennock | Officer (Chief Medical Officer) | A | ▲ buy | 54,240→ 54,240 Voting Common Stock | — | — | 54,240 | — | — | filing |
| 2026-08-19 | Foff Erin Pennock | Officer (Chief Medical Officer) | A | ▲ buy | 13,3600 | — | — | 312,261 | +4% | +0.03% (now 0.74%) | filing |
| 2026-08-04 | Lillie James Woodruff | Officer (Chief Scientific Officer) | S | ▼ sell10b5-1 | 22,0820 | $12.54 | $276.9K | 202,380 | −10% | −0.05% (now 0.48%) | filing |
| 2026-07-28 | Cox Troy | Director | P | ▲ buy | 15,6200 | $9.52 | $148.7K | 15,620 | new | +0.04% (now 0.04%) | filing |
| 2026-07-20 | GILLIS JONATHAN | Officer (CAO and Interim CFO) | S | ▼ sell10b5-1 | 9000 | $38.17 | $34.4K | 144,240 | −0.6% | −<0.01% (now 0.34%) | filing |
| 2026-07-20 | GILLIS JONATHAN | Officer (CAO and Interim CFO) | S | ▼ sell10b5-1 | 16,9690 | $37.61 | $638.2K | 145,140 | −10% | −0.04% (now 0.34%) | filing |
| 2026-07-20 | GILLIS JONATHAN | Officer (CAO and Interim CFO) | S | ▼ sell10b5-1 | 6000 | $36.51 | $21.9K | 162,109 | −0.4% | −<0.01% (now 0.38%) | filing |
| 2026-07-20 | GILLIS JONATHAN | Officer (CAO and Interim CFO) | S | ▼ sell10b5-1 | 1,4760 | $37.44 | $55.3K | 162,709 | −0.9% | −<0.01% (now 0.38%) | filing |
| 2026-07-20 | GILLIS JONATHAN | Officer (CAO and Interim CFO) | S | ▼ sell10b5-1 | 6,9790 | $36.66 | $255.9K | 164,185 | −4% | −0.02% (now 0.39%) | filing |
| 2026-07-20 | GILLIS JONATHAN | Officer (CAO and Interim CFO) | S | ▼ sell10b5-1 | 4,6990 | $36.94 | $173.6K | 171,164 | −3% | −0.01% (now 0.40%) | filing |
| 2026-07-20 | GILLIS JONATHAN | Officer (CAO and Interim CFO) | S | ▼ sell10b5-1 | 5,3560 | $36.13 | $193.5K | 175,863 | −3% | −0.01% (now 0.41%) | filing |
| 2026-07-20 | Kreitzer Anatol | Officer (Chief Discovery Officer) | S | ▼ sell10b5-1 | 2000 | $38.39 | $7.7K | 174,906 | −0.1% | −<0.01% (now 0.41%) | filing |
| 2026-07-20 | Kreitzer Anatol | Officer (Chief Discovery Officer) | S | ▼ sell10b5-1 | 14,1400 | $37.70 | $533.1K | 175,106 | −7% | −0.03% (now 0.41%) | filing |
| 2026-07-20 | Kreitzer Anatol | Officer (Chief Discovery Officer) | S | ▼ sell10b5-1 | 2,8330 | $37.05 | $105.0K | 189,246 | −1% | −<0.01% (now 0.45%) | filing |
| 2026-07-20 | Kreitzer Anatol | Officer (Chief Discovery Officer) | S | ▼ sell10b5-1 | 1,5920 | $37.44 | $59.6K | 192,079 | −0.8% | −<0.01% (now 0.45%) | filing |
| 2026-07-20 | Kreitzer Anatol | Officer (Chief Discovery Officer) | S | ▼ sell10b5-1 | 7,4640 | $36.66 | $273.6K | 193,671 | −4% | −0.02% (now 0.46%) | filing |
| 2026-07-20 | Kreitzer Anatol | Officer (Chief Discovery Officer) | S | ▼ sell10b5-1 | 4,5100 | $36.94 | $166.6K | 201,135 | −2% | −0.01% (now 0.47%) | filing |
| 2026-07-20 | Kreitzer Anatol | Officer (Chief Discovery Officer) | S | ▼ sell10b5-1 | 5,5450 | $36.13 | $200.3K | 205,645 | −3% | −0.01% (now 0.48%) | filing |
| 2026-07-17 | Kroeger Christopher A. | Director, Officer (Chief Executive Officer) | S | ▼ sell | 16,7790 | $37.90 | $635.9K | 1,246,455 | −1% | −0.04% (now 2.9%) | filing |
| 2026-07-17 | Kroeger Christopher A. | Director, Officer (Chief Executive Officer) | S | ▼ sell | 920 | $37.96 | $3.5K | 1,263,234 | −<0.1% | −<0.01% (now 3.0%) | filing |
| 2026-07-17 | Kroeger Christopher A. | Director, Officer (Chief Executive Officer) | S | ▼ sell | 28,0910 | $37.26 | $1.05M | 1,263,326 | −2% | −0.07% (now 3.0%) | filing |
| 2026-07-17 | Kroeger Christopher A. | Director, Officer (Chief Executive Officer) | S | ▼ sell | 40,8990 | $36.46 | $1.49M | 1,291,417 | −3% | −0.10% (now 3.0%) | filing |
| 2026-07-17 | Kroeger Christopher A. | Director, Officer (Chief Executive Officer) | S | ▼ sell | 900 | $37.54 | $3.4K | 1,332,316 | −<0.1% | −<0.01% (now 3.1%) | filing |
| 2026-07-17 | Kroeger Christopher A. | Director, Officer (Chief Executive Officer) | S | ▼ sell | 42,7380 | $36.99 | $1.58M | 1,332,406 | −3% | −0.10% (now 3.1%) | filing |
| 2026-07-17 | Kroeger Christopher A. | Director, Officer (Chief Executive Officer) | S | ▼ sell | 18,9500 | $36.00 | $682.2K | 1,375,144 | −1% | −0.04% (now 3.2%) | filing |
| 2026-07-17 | Lillie James Woodruff | Officer (Chief Scientific Officer) | S | ▼ sell | 2,0770 | $37.90 | $78.7K | 224,462 | −0.9% | −<0.01% (now 0.53%) | filing |
| 2026-07-17 | Lillie James Woodruff | Officer (Chief Scientific Officer) | S | ▼ sell | 120 | $37.96 | $456 | 226,539 | −<0.1% | −<0.01% (now 0.53%) | filing |
| 2026-07-17 | Lillie James Woodruff | Officer (Chief Scientific Officer) | S | ▼ sell | 3,5260 | $37.26 | $131.4K | 226,551 | −2% | −<0.01% (now 0.53%) | filing |
| 2026-07-17 | Lillie James Woodruff | Officer (Chief Scientific Officer) | S | ▼ sell | 5,0090 | $36.45 | $182.6K | 230,077 | −2% | −0.01% (now 0.54%) | filing |
| 2026-07-17 | Lillie James Woodruff | Officer (Chief Scientific Officer) | S | ▼ sell | 120 | $37.54 | $450 | 235,086 | −<0.1% | −<0.01% (now 0.55%) | filing |
| 2026-07-17 | Lillie James Woodruff | Officer (Chief Scientific Officer) | S | ▼ sell | 5,3930 | $36.99 | $199.5K | 235,098 | −2% | −0.01% (now 0.55%) | filing |
| 2026-07-17 | Lillie James Woodruff | Officer (Chief Scientific Officer) | S | ▼ sell | 2,2380 | $36.00 | $80.6K | 240,491 | −0.9% | −<0.01% (now 0.57%) | filing |
| 2026-07-17 | Hanson Kristopher | Officer (General Counsel) | S | ▼ sell | 1,1300 | $37.90 | $42.8K | 145,823 | −0.8% | −<0.01% (now 0.34%) | filing |
| 2026-07-17 | Hanson Kristopher | Officer (General Counsel) | S | ▼ sell | 110 | $37.96 | $418 | 146,953 | −<0.1% | −<0.01% (now 0.35%) | filing |
| 2026-07-17 | Hanson Kristopher | Officer (General Counsel) | S | ▼ sell | 3,3310 | $37.26 | $124.1K | 146,964 | −2% | −<0.01% (now 0.35%) | filing |
| 2026-07-17 | Hanson Kristopher | Officer (General Counsel) | S | ▼ sell | 4,7760 | $36.45 | $174.1K | 150,295 | −3% | −0.01% (now 0.35%) | filing |
| 2026-07-17 | Hanson Kristopher | Officer (General Counsel) | S | ▼ sell | 100 | $37.54 | $375 | 155,071 | −<0.1% | −<0.01% (now 0.37%) | filing |
| 2026-07-17 | Hanson Kristopher | Officer (General Counsel) | S | ▼ sell | 5,1030 | $36.99 | $188.8K | 155,081 | −3% | −0.01% (now 0.37%) | filing |
| 2026-07-17 | Hanson Kristopher | Officer (General Counsel) | S | ▼ sell | 2,1470 | $36.00 | $77.3K | 160,184 | −1% | −<0.01% (now 0.38%) | filing |
| 2026-07-17 | Foff Erin Pennock | Officer (Chief Medical Officer) | S | ▼ sell10b5-1 | 3,6560 | $37.90 | $138.6K | 298,901 | −1% | −<0.01% (now 0.70%) | filing |
| 2026-07-17 | Foff Erin Pennock | Officer (Chief Medical Officer) | S | ▼ sell10b5-1 | 190 | $37.96 | $721 | 302,557 | −<0.1% | −<0.01% (now 0.71%) | filing |
| 2026-07-17 | Foff Erin Pennock | Officer (Chief Medical Officer) | S | ▼ sell10b5-1 | 5,8650 | $37.26 | $218.5K | 302,576 | −2% | −0.01% (now 0.71%) | filing |
| 2026-07-17 | Foff Erin Pennock | Officer (Chief Medical Officer) | S | ▼ sell10b5-1 | 9,1630 | $36.46 | $334.1K | 308,441 | −3% | −0.02% (now 0.73%) | filing |
| 2026-07-17 | Foff Erin Pennock | Officer (Chief Medical Officer) | S | ▼ sell10b5-1 | 180 | $37.54 | $676 | 317,604 | −<0.1% | −<0.01% (now 0.75%) | filing |
| 2026-07-17 | Foff Erin Pennock | Officer (Chief Medical Officer) | S | ▼ sell10b5-1 | 8,9720 | $36.99 | $331.9K | 317,622 | −3% | −0.02% (now 0.75%) | filing |
| 2026-07-17 | Foff Erin Pennock | Officer (Chief Medical Officer) | S | ▼ sell10b5-1 | 4,4650 | $36.00 | $160.7K | 326,594 | −1% | −0.01% (now 0.77%) | filing |
| 2026-07-17 | Foff Erin Pennock | Officer (Chief Medical Officer) | S | ▼ sell10b5-1 | 7,8450 | $37.04 | $290.6K | 331,059 | −2% | −0.02% (now 0.78%) | filing |
| 2026-07-17 | Foff Erin Pennock | Officer (Chief Medical Officer) | S | ▼ sell10b5-1 | 7,1550 | $36.16 | $258.7K | 338,904 | −2% | −0.02% (now 0.80%) | filing |
| 2026-06-25 | Cox Troy | Director | A | ▲ buy | 29,804→ 29,804 Voting Common Stock | — | — | 29,804 | — | — | filing |
| 2026-06-25 | Cox Troy | Director | A | ▲ buy | 7,8640 | — | — | 7,864 | new | +0.02% (now 0.02%) | filing |
| 2026-06-25 | Babler Martin | Director | A | ▲ buy | 29,804→ 29,804 Voting Common Stock | — | — | 29,804 | — | — | filing |
| 2026-06-25 | Babler Martin | Director | A | ▲ buy | 7,8640 | — | — | 7,864 | new | +0.02% (now 0.02%) | filing |
| 2026-06-25 | Garnett Timothy John | Director | A | ▲ buy | 14,902→ 14,902 Voting Common Stock | — | — | 14,902 | — | — | filing |
| 2026-06-25 | Garnett Timothy John | Director | A | ▲ buy | 3,9320 | — | — | 53,457 | +8% | +<0.01% (now 0.13%) | filing |
| 2026-06-25 | Luneborg Nanna Liebach | Director | A | ▲ buy | 14,902→ 14,902 Voting Common Stock | — | — | 14,902 | — | — | filing |
| 2026-06-25 | Luneborg Nanna Liebach | Director | A | ▲ buy | 3,9320 | — | — | 3,932 | new | +<0.01% (now <0.01%) | filing |
| 2026-06-25 | Pavlov George | Director | A | ▲ buy | 14,902→ 14,902 Voting Common Stock | — | — | 14,902 | — | — | filing |
| 2026-06-25 | Pavlov George | Director | A | ▲ buy | 3,9320 | — | — | 28,932 | +16% | +<0.01% (now 0.07%) | filing |
| 2026-06-25 | Walker Maria C | Director | A | ▲ buy | 14,902→ 14,902 Voting Common Stock | — | — | 14,902 | — | — | filing |
| 2026-06-25 | Walker Maria C | Director | A | ▲ buy | 3,9320 | — | — | 62,703 | +7% | +<0.01% (now 0.15%) | filing |
| 2026-05-18 | Kroeger Christopher A. | Director, Officer (Chief Executive Officer) | S | ▼ sell10b5-1 | 1980 | $28.15 | $5.6K | 1,394,094 | −<0.1% | −<0.01% (now 3.3%) | filing |
| 2026-05-18 | Kroeger Christopher A. | Director, Officer (Chief Executive Officer) | S | ▼ sell10b5-1 | 118,0370 | $27.19 | $3.21M | 1,394,292 | −8% | −0.28% (now 3.3%) | filing |
| 2026-05-11 | Lillie James Woodruff | Officer (Chief Scientific Officer) | S | ▼ sell10b5-1 | 7210 | $28.28 | $20.4K | 242,729 | −0.3% | −<0.01% (now 0.57%) | filing |
| 2026-05-11 | Kroeger Christopher A. | Director, Officer (Chief Executive Officer) | S | ▼ sell10b5-1 | 5,8900 | $30.56 | $180.0K | 1,512,329 | −0.4% | −0.01% (now 3.6%) | filing |
| 2026-05-11 | Kroeger Christopher A. | Director, Officer (Chief Executive Officer) | S | ▼ sell10b5-1 | 6,8710 | $30.04 | $206.4K | 1,518,219 | −0.5% | −0.02% (now 3.6%) | filing |
| 2026-05-11 | Kroeger Christopher A. | Director, Officer (Chief Executive Officer) | S | ▼ sell10b5-1 | 8770 | $28.70 | $25.2K | 1,525,090 | −<0.1% | −<0.01% (now 3.6%) | filing |
| 2026-05-11 | Kroeger Christopher A. | Director, Officer (Chief Executive Officer) | S | ▼ sell10b5-1 | 3420 | $27.57 | $9.4K | 1,525,967 | −<0.1% | −<0.01% (now 3.6%) | filing |
| 2026-05-11 | Kroeger Christopher A. | Director, Officer (Chief Executive Officer) | S | ▼ sell10b5-1 | 3,2050 | $29.20 | $93.6K | 1,526,309 | −0.2% | −<0.01% (now 3.6%) | filing |
| 2026-05-11 | Kroeger Christopher A. | Director, Officer (Chief Executive Officer) | S | ▼ sell10b5-1 | 1,5820 | $28.56 | $45.2K | 1,529,514 | −0.1% | −<0.01% (now 3.6%) | filing |
| 2026-05-11 | Kroeger Christopher A. | Director, Officer (Chief Executive Officer) | S | ▼ sell10b5-1 | 29,6240 | $27.48 | $814.1K | 1,531,096 | −2% | −0.07% (now 3.6%) | filing |
| 2026-05-11 | Kroeger Christopher A. | Director, Officer (Chief Executive Officer) | S | ▼ sell10b5-1 | 5,2200 | $29.15 | $152.2K | 1,560,720 | −0.3% | −0.01% (now 3.7%) | filing |
| 2026-05-11 | Kroeger Christopher A. | Director, Officer (Chief Executive Officer) | S | ▼ sell10b5-1 | 14,8800 | $28.47 | $423.6K | 1,565,940 | −0.9% | −0.04% (now 3.7%) | filing |
| 2026-05-11 | Hanson Kristopher | Officer (General Counsel) | S | ▼ sell10b5-1 | 5,8080 | $30.56 | $177.5K | 162,331 | −3% | −0.01% (now 0.38%) | filing |
| 2026-05-11 | Hanson Kristopher | Officer (General Counsel) | S | ▼ sell10b5-1 | 6,9790 | $30.04 | $209.6K | 168,139 | −4% | −0.02% (now 0.40%) | filing |
| 2026-05-11 | Hanson Kristopher | Officer (General Counsel) | S | ▼ sell10b5-1 | 8460 | $28.70 | $24.3K | 175,118 | −0.5% | −<0.01% (now 0.41%) | filing |
| 2026-05-11 | Hanson Kristopher | Officer (General Counsel) | S | ▼ sell10b5-1 | 2840 | $27.61 | $7.8K | 175,964 | −0.2% | −<0.01% (now 0.41%) | filing |
| 2026-05-11 | Foff Erin Pennock | Officer (Chief Medical Officer) | S | ▼ sell10b5-1 | 1170 | $29.10 | $3.4K | 346,059 | −<0.1% | −<0.01% (now 0.82%) | filing |
| 2026-05-11 | Foff Erin Pennock | Officer (Chief Medical Officer) | S | ▼ sell10b5-1 | 4,3210 | $28.52 | $123.2K | 346,176 | −1% | −0.01% (now 0.82%) | filing |
| 2026-05-06 | Setia Vishwas | Officer (Chief Financial Officer) | S | ▼ sell10b5-1 | 2,0680 | $29.07 | $60.1K | 356,256 | −0.6% | −<0.01% (now 0.84%) | filing |
| 2026-05-06 | Setia Vishwas | Officer (Chief Financial Officer) | S | ▼ sell10b5-1 | 8,4960 | $28.04 | $238.2K | 358,324 | −2% | −0.02% (now 0.84%) | filing |
| 2026-05-06 | Setia Vishwas | Officer (Chief Financial Officer) | S | ▼ sell10b5-1 | 9680 | $29.00 | $28.1K | 366,820 | −0.3% | −<0.01% (now 0.86%) | filing |
| 2026-05-06 | Setia Vishwas | Officer (Chief Financial Officer) | S | ▼ sell10b5-1 | 9,9350 | $28.12 | $279.4K | 367,788 | −3% | −0.02% (now 0.87%) | filing |
| 2026-05-06 | Setia Vishwas | Officer (Chief Financial Officer) | S | ▼ sell10b5-1 | 7870 | $30.12 | $23.7K | 377,723 | −0.2% | −<0.01% (now 0.89%) | filing |
| 2026-05-06 | Setia Vishwas | Officer (Chief Financial Officer) | S | ▼ sell10b5-1 | 3250 | $29.56 | $9.6K | 378,510 | −<0.1% | −<0.01% (now 0.89%) | filing |
| 2026-05-06 | Setia Vishwas | Officer (Chief Financial Officer) | S | ▼ sell10b5-1 | 8,9890 | $28.28 | $254.2K | 378,835 | −2% | −0.02% (now 0.89%) | filing |
| 2026-05-06 | Setia Vishwas | Officer (Chief Financial Officer) | S | ▼ sell10b5-1 | 4,8030 | $27.36 | $131.4K | 387,824 | −1% | −0.01% (now 0.91%) | filing |
| 2026-05-06 | Lillie James Woodruff | Officer (Chief Scientific Officer) | S | ▼ sell10b5-1 | 16,4210 | $29.13 | $478.3K | 243,450 | −6% | −0.04% (now 0.57%) | filing |
| 2026-05-06 | Lillie James Woodruff | Officer (Chief Scientific Officer) | S | ▼ sell10b5-1 | 8,3900 | $28.04 | $235.3K | 259,871 | −3% | −0.02% (now 0.61%) | filing |
| 2026-05-06 | Lillie James Woodruff | Officer (Chief Scientific Officer) | S | ▼ sell10b5-1 | 9630 | $29.00 | $27.9K | 268,261 | −0.4% | −<0.01% (now 0.63%) | filing |
| 2026-05-06 | Lillie James Woodruff | Officer (Chief Scientific Officer) | S | ▼ sell10b5-1 | 10,1320 | $28.12 | $284.9K | 269,224 | −4% | −0.02% (now 0.63%) | filing |
| 2026-05-06 | Lillie James Woodruff | Officer (Chief Scientific Officer) | S | ▼ sell10b5-1 | 7050 | $30.08 | $21.2K | 279,356 | −0.3% | −<0.01% (now 0.66%) | filing |
| 2026-05-06 | Lillie James Woodruff | Officer (Chief Scientific Officer) | S | ▼ sell10b5-1 | 3200 | $29.56 | $9.5K | 280,061 | −0.1% | −<0.01% (now 0.66%) | filing |
| 2026-05-06 | Lillie James Woodruff | Officer (Chief Scientific Officer) | S | ▼ sell10b5-1 | 5,5260 | $28.37 | $156.8K | 280,381 | −2% | −0.01% (now 0.66%) | filing |
| 2026-05-06 | Lillie James Woodruff | Officer (Chief Scientific Officer) | S | ▼ sell10b5-1 | 9,2500 | $27.50 | $254.4K | 285,907 | −3% | −0.02% (now 0.67%) | filing |
| 2026-05-06 | Kroeger Christopher A. | Director, Officer (Chief Executive Officer) | S | ▼ sell10b5-1 | 15,6030 | $29.13 | $454.5K | 1,580,820 | −1.0% | −0.04% (now 3.7%) | filing |
| 2026-05-06 | Kroeger Christopher A. | Director, Officer (Chief Executive Officer) | S | ▼ sell10b5-1 | 8,0980 | $28.04 | $227.1K | 1,596,423 | −0.5% | −0.02% (now 3.8%) | filing |
| 2026-05-06 | Kroeger Christopher A. | Director, Officer (Chief Executive Officer) | S | ▼ sell10b5-1 | 9280 | $29.00 | $26.9K | 1,604,521 | −<0.1% | −<0.01% (now 3.8%) | filing |
| 2026-05-06 | Kroeger Christopher A. | Director, Officer (Chief Executive Officer) | S | ▼ sell10b5-1 | 9,5440 | $28.12 | $268.4K | 1,605,449 | −0.6% | −0.02% (now 3.8%) | filing |
| 2026-05-06 | Kroeger Christopher A. | Director, Officer (Chief Executive Officer) | S | ▼ sell10b5-1 | 6970 | $30.08 | $21.0K | 1,614,993 | −<0.1% | −<0.01% (now 3.8%) | filing |
| 2026-05-06 | Kroeger Christopher A. | Director, Officer (Chief Executive Officer) | S | ▼ sell10b5-1 | 3110 | $29.56 | $9.2K | 1,615,690 | −<0.1% | −<0.01% (now 3.8%) | filing |
| 2026-05-06 | Kroeger Christopher A. | Director, Officer (Chief Executive Officer) | S | ▼ sell10b5-1 | 5,4270 | $28.37 | $154.0K | 1,616,001 | −0.3% | −0.01% (now 3.8%) | filing |
| 2026-05-06 | Kroeger Christopher A. | Director, Officer (Chief Executive Officer) | S | ▼ sell10b5-1 | 9,1360 | $27.50 | $251.2K | 1,621,428 | −0.6% | −0.02% (now 3.8%) | filing |
| 2026-05-06 | Hanson Kristopher | Officer (General Counsel) | S | ▼ sell10b5-1 | 6830 | $30.08 | $20.5K | 176,248 | −0.4% | −<0.01% (now 0.42%) | filing |
| 2026-05-06 | Hanson Kristopher | Officer (General Counsel) | S | ▼ sell10b5-1 | 2960 | $29.56 | $8.7K | 176,931 | −0.2% | −<0.01% (now 0.42%) | filing |
| 2026-05-06 | Hanson Kristopher | Officer (General Counsel) | S | ▼ sell10b5-1 | 3,9080 | $28.29 | $110.6K | 177,227 | −2% | −<0.01% (now 0.42%) | filing |
| 2026-05-06 | Hanson Kristopher | Officer (General Counsel) | S | ▼ sell10b5-1 | 9,0300 | $27.50 | $248.3K | 181,135 | −5% | −0.02% (now 0.43%) | filing |
| 2026-05-06 | Foff Erin Pennock | Officer (Chief Medical Officer) | S | ▼ sell10b5-1 | 15,9000 | $29.13 | $463.2K | 350,497 | −4% | −0.04% (now 0.83%) | filing |
| 2026-05-06 | Foff Erin Pennock | Officer (Chief Medical Officer) | S | ▼ sell10b5-1 | 8,1520 | $28.04 | $228.6K | 366,397 | −2% | −0.02% (now 0.86%) | filing |
| 2026-05-06 | Foff Erin Pennock | Officer (Chief Medical Officer) | S | ▼ sell10b5-1 | 9310 | $29.00 | $27.0K | 374,549 | −0.2% | −<0.01% (now 0.88%) | filing |
| 2026-05-06 | Foff Erin Pennock | Officer (Chief Medical Officer) | S | ▼ sell10b5-1 | 9,6450 | $28.12 | $271.2K | 375,480 | −3% | −0.02% (now 0.88%) | filing |
| 2026-05-06 | Foff Erin Pennock | Officer (Chief Medical Officer) | S | ▼ sell10b5-1 | 7000 | $30.08 | $21.1K | 385,125 | −0.2% | −<0.01% (now 0.91%) | filing |
| 2026-05-06 | Foff Erin Pennock | Officer (Chief Medical Officer) | S | ▼ sell10b5-1 | 3120 | $29.56 | $9.2K | 385,825 | −<0.1% | −<0.01% (now 0.91%) | filing |
| 2026-05-06 | Foff Erin Pennock | Officer (Chief Medical Officer) | S | ▼ sell10b5-1 | 5,4600 | $28.37 | $154.9K | 386,137 | −1% | −0.01% (now 0.91%) | filing |
| 2026-05-06 | Foff Erin Pennock | Officer (Chief Medical Officer) | S | ▼ sell10b5-1 | 9,1800 | $27.50 | $252.4K | 391,597 | −2% | −0.02% (now 0.92%) | filing |
| 2026-04-29 | Kreitzer Anatol | Officer (Chief Discovery Officer) | S | ▼ sell10b5-1 | 7,8210 | $30.50 | $238.5K | 211,190 | −4% | −0.02% (now 0.50%) | filing |
| 2026-04-29 | Kreitzer Anatol | Officer (Chief Discovery Officer) | S | ▼ sell10b5-1 | 29,2550 | $29.63 | $866.8K | 219,011 | −12% | −0.07% (now 0.52%) | filing |
| 2026-04-29 | Kreitzer Anatol | Officer (Chief Discovery Officer) | S | ▼ sell10b5-1 | 8,3460 | $28.96 | $241.7K | 248,266 | −3% | −0.02% (now 0.59%) | filing |
| 2026-04-29 | GILLIS JONATHAN | Officer (CAAO and PAO) | S | ▼ sell10b5-1 | 7000 | $30.83 | $21.6K | 181,219 | −0.4% | −<0.01% (now 0.43%) | filing |
| 2026-04-29 | GILLIS JONATHAN | Officer (CAAO and PAO) | S | ▼ sell10b5-1 | 17,2350 | $30.33 | $522.7K | 181,919 | −9% | −0.04% (now 0.43%) | filing |
| 2026-04-29 | GILLIS JONATHAN | Officer (CAAO and PAO) | S | ▼ sell10b5-1 | 14,3630 | $30.46 | $437.5K | 199,154 | −7% | −0.03% (now 0.47%) | filing |
| 2026-04-29 | GILLIS JONATHAN | Officer (CAAO and PAO) | S | ▼ sell10b5-1 | 29,6230 | $29.60 | $876.8K | 213,517 | −12% | −0.07% (now 0.50%) | filing |
| 2026-04-29 | GILLIS JONATHAN | Officer (CAAO and PAO) | S | ▼ sell10b5-1 | 7,9140 | $28.94 | $229.0K | 243,140 | −3% | −0.02% (now 0.57%) | filing |
| 2026-04-17 | Setia Vishwas | Officer (Chief Financial Officer) | S | ▼ sell | 870 | $27.49 | $2.4K | 392,627 | −<0.1% | −<0.01% (now 0.93%) | filing |
| 2026-04-17 | Setia Vishwas | Officer (Chief Financial Officer) | S | ▼ sell | 290 | $27.01 | $783 | 392,714 | −<0.1% | −<0.01% (now 0.93%) | filing |
| 2026-04-17 | Setia Vishwas | Officer (Chief Financial Officer) | S | ▼ sell | 2,8060 | $26.87 | $75.4K | 392,743 | −0.7% | −<0.01% (now 0.93%) | filing |
| 2026-04-17 | Malenka Robert C. | Director | S | ▼ sell10b5-1 | 8,5930 | $26.90 | $231.2K | 316,466 | −3% | −0.02% (now 0.75%) | filing |
| 2026-04-17 | Lillie James Woodruff | Officer (Chief Scientific Officer) | S | ▼ sell | 2,0970 | $27.49 | $57.6K | 295,157 | −0.7% | −<0.01% (now 0.70%) | filing |
| 2026-04-17 | Lillie James Woodruff | Officer (Chief Scientific Officer) | S | ▼ sell | 6860 | $27.01 | $18.5K | 297,254 | −0.2% | −<0.01% (now 0.70%) | filing |
| 2026-04-17 | Lillie James Woodruff | Officer (Chief Scientific Officer) | S | ▼ sell | 1,7300 | $26.82 | $46.4K | 297,940 | −0.6% | −<0.01% (now 0.70%) | filing |
| 2026-04-17 | Kroeger Christopher A. | Director, Officer (Chief Executive Officer) | S | ▼ sell | 7,5750 | $27.49 | $208.2K | 1,630,564 | −0.5% | −0.02% (now 3.8%) | filing |
| 2026-04-17 | Kroeger Christopher A. | Director, Officer (Chief Executive Officer) | S | ▼ sell | 2,4770 | $27.01 | $66.9K | 1,638,139 | −0.2% | −<0.01% (now 3.9%) | filing |
| 2026-04-17 | Kroeger Christopher A. | Director, Officer (Chief Executive Officer) | S | ▼ sell | 9,1350 | $26.93 | $246.0K | 1,640,616 | −0.6% | −0.02% (now 3.9%) | filing |
| 2026-04-17 | Kreitzer Anatol | Officer (Chief Discovery Officer) | S | ▼ sell | 3,3160 | $26.61 | $88.2K | 256,612 | −1% | −<0.01% (now 0.60%) | filing |
| 2026-04-17 | Hanson Kristopher | Officer (General Counsel) | S | ▼ sell | 2250 | $27.49 | $6.2K | 190,165 | −0.1% | −<0.01% (now 0.45%) | filing |
| 2026-04-17 | Hanson Kristopher | Officer (General Counsel) | S | ▼ sell | 730 | $27.01 | $2.0K | 190,390 | −<0.1% | −<0.01% (now 0.45%) | filing |
| 2026-04-17 | Hanson Kristopher | Officer (General Counsel) | S | ▼ sell | 1,5290 | $26.80 | $41.0K | 190,463 | −0.8% | −<0.01% (now 0.45%) | filing |
| 2026-04-17 | GILLIS JONATHAN | Officer (CAAO and PAO) | S | ▼ sell | 3,5900 | $26.61 | $95.5K | 251,054 | −1% | −<0.01% (now 0.59%) | filing |
| 2026-04-17 | Foff Erin Pennock | Officer (Chief Medical Officer) | S | ▼ sell | 8810 | $27.49 | $24.2K | 400,777 | −0.2% | −<0.01% (now 0.94%) | filing |
| 2026-04-17 | Foff Erin Pennock | Officer (Chief Medical Officer) | S | ▼ sell | 2880 | $27.01 | $7.8K | 401,658 | −<0.1% | −<0.01% (now 0.95%) | filing |
| 2026-04-17 | Foff Erin Pennock | Officer (Chief Medical Officer) | S | ▼ sell | 2,0440 | $26.84 | $54.9K | 401,946 | −0.5% | −<0.01% (now 0.95%) | filing |
Up to 200 most recent filings · select a heading to sort, or open “How to read this” above for definitions · this company on SEC EDGAR.